entertainment -WSS

entertainment

author：knowledge 2025-09-30 03:33:14 - browse：1166

Silhouette of a person with short hair taking a sip of red wine in a winery — coverage from STAT — MARCO BERTORELLO/AFP via Getty Images

In 1995, when Marion Nestle was on the committee drafting the Dietary Guidelines for Americans, things were run differently. She and other experts handled it all: deciding on nutrition-related research questions, collecting the evidence, issuing a scientific report, and then writing guidance for how Americans should eat.

When it came time for that last part — the writing — Nestle and two co-authors got together at a bar, ordered glasses of wine, and got to work. “I’m not kidding,” she said. At the time, the research suggested small amounts of alcohol reduced the risk of heart disease. The guidelines reflected that. “Alcoholic beverages have been used to enhance the enjoyment of meals by many societies throughout human history,” read a part of the 1995 document (a note Nestle says was added last-minute by a federal official who believed in wine’s benefits).

The issue of alcohol — and how much of it Americans should consume — is up for debate again as the dietary guidelines undergo updates and revisions, due in 2025. Already, there’s simmering debate over a growing body of research, plus clashing of interests and the same specter of controversy that’s followed the report since Nestle’s time.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Doctor of U.S. President Joe Biden says he is fit for duty

WSS

Ohio train derailment: Experts on toxic chemical risks

Elisabeth Bik tackles the widespread issue of research misconduct

Study fuels hope CAR

Childhood vaccination ad campaign launches in the U.K.

First U.S. drug developed to treat liver disease MASH is approved

FDA advisers back CAR

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Male and female sex labels in research insufficient, scientists say

How to save PrEP access — and even expand it

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

The cancer drug shortage isn’t new — and neither are the solutions

How many hemophilia patients actually want gene therapy?

Heart attack and stroke risk calculators need revising

How to save health care price transparency rules

New air purifier tech could be key to improving indoor air quality

Change Healthcare cyberattack shows risk of industry consolidation

focus

Medicare isn't yet testing food as medicine

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Neuroscience renaissance leads to new crop of psychiatric drugs

Amid AI frenzy, a top HHS official's quest to create safeguards

Steward Health Care Massachusetts hospitals face fiscal disaster

focus

focus

explore

focus